News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
JORDAN ANDREW R
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/19/2023 |
4
| JORDAN ANDREW R (Chief Strategy Officer) has filed a Form 4 on Aceragen, Inc.
Txns:
| Exercised 6,843 options to buy
@ $0 |
|
01/10/2023 |
4
| JORDAN ANDREW R (CHIEF STRATEGY OFFICER) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.
Txns:
| Granted 261,718 shares
@ $0 Paid exercise price by delivering 73,940 shares
@ $0.7099, valued at
$52.5k
|
|
09/30/2022 |
4
| JORDAN ANDREW R (Chief Strategy Officer) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.
Txns:
| Granted 651,364 shares
@ $0 Granted 6,843 options to buy
@ $0 |
|
09/30/2022 |
3
| JORDAN ANDREW R (Chief Strategy Officer) has filed a Form 3 on IDERA PHARMACEUTICALS, INC. |
02/12/2004 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
02/14/2003 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
|
|